hepatitis b surface antigen loss and kinetic in chronic hepatitis b patients during interferon alpha treatment: a hospital-based real-world data analysis
首发时间:2024-07-22
abstract:background: the sustained loss of hepatitis b surface antigen (hbsag) is an important alternative marker for chronic hepatitis b (chb) functional cure, but the predictor for hbsag loss and kinetic of related viral serological patterns in these uncured patients undergone long-term pegylated interferon alpha treatment remains insufficient. methods: retrospective data on chb patients who were admitted to our institutions from may 30, 2018, to january 30, 2023, were collected, which are mostly regular weekly data. a total of 382 patients were enrolled for follow-up analysis, including 232 immune-inactive stage patients and 150 immune-active stage patients, and 95 patients achieved functional cure. binary logistic regression analysis and profile analysis were performed to explore predictive factors for hbsag loss and describe the kinetic patterns of the hbsag continuously positive (cp) patients. results: besides baseline hbsag, age was also the predictor for hbsag loss for immune-inactive stages patients, and the suggested cut-off baseline hbsag were obtained. for cp patients, both two immune stage groups exhibited a gradually decreasing kinetic pattern in hbsag, but there was a reversal kinetic pattern between two immune stage groups in alanine aminotransferase (alt). the difference of hbsag and alt kinetic was mainly reflected in the first 24 weeks after treatment. female and hepatitis b e antigen (hbeag) positive patients had a faster hbsag decline rate than male and hbeag negative patients respectively. conclusions: clinical consequence of hbsag conversion and kinetic are not only correlated with clinical course status, but also related to gender and hbeag grouping (negative/positive).
keywords: chronic hepatitis b interferon therapy multivariable analysis kinetic pattern profile analysis
点击查看论文中文信息
干扰素α治疗期间慢性乙型肝炎患者的乙型肝炎表面抗原丢失和动力学:基于医院的真实数据分析
摘要:背景:乙型肝炎表面抗原(hbsag)的持续丢失是慢性乙型肝炎(chb)功能性治愈的重要替代标志物,但在这些接受长期聚乙二醇干扰素α治疗的未治愈患者中,hbsag丢失的预测因素和相关病毒血清学模式的动力学仍然不足。方法:收集2018年5月30日至2023年1月30日期间我院收治的慢性乙型肝炎患者的回顾性数据,这些数据大多为每周定期数据。共招募382名患者进行随访分析,包括232名免疫失活期患者和150名免疫活跃期患者,其中95名患者实现了功能性治愈。进行二元逻辑回归分析和轮廓分析,以探索hbsag丢失的预测因素,并描述hbsag持续阳性(cp)患者的动力学模式。结果:除了基线hbsag外,年龄也是免疫失活期患者hbsag丢失的预测因素,并获得了建议的基线hbsag临界值。对于cp患者,两个免疫阶段组的hbsag均呈逐渐下降的动力学模式,但丙氨酸氨基转移酶(alt)在两个免疫期组之间呈逆转的动力学模式。hbsag和alt动力学的差异主要反映在治疗后的前24周。女性和hbeag阳性患者的hbsag下降速度分别快于男性和hbeag阴性患者。结论:hbsag转化和动力学的临床结果不仅与临床病程状态有关,还与性别和hbeag分组(阴性/阳性)有关。
基金:
论文图表:
引用
导出参考文献
no.****
动态公开评议
共计0人参与
勘误表
干扰素α治疗期间慢性乙型肝炎患者的乙型肝炎表面抗原丢失和动力学:基于医院的真实数据分析
评论
全部评论